Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Cibus, Inc.
Report date March 01, 2023 · Filed June 03, 2023
Section 16 reporting ended · disclosed 2023-06-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,060 |
Reported balance
After 2023-05-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-05-31 · Grant · Acquired 5,733 · Balance 19,060 F1: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect the one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.55 · Expires 2030-08-04 | Direct | 0 |
Reported balance
After 2023-03-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-03-01 · Disposition to issuer · Disposed 80,000 · Balance 0 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.55 · Expires 2030-08-04 | Direct | 80,000 |
Reported balance
After 2023-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-01 · Grant · Acquired 80,000 · Balance 80,000 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.05 · Expires 2031-03-12 | Direct | 0 |
Reported balance
After 2023-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-03-01 · Disposition to issuer · Disposed 24,000 · Balance 0 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.05 · Expires 2031-03-12 | Direct | 24,000 |
Reported balance
After 2023-03-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-03-01 · Grant · Acquired 24,000 · Balance 24,000 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.27 · Expires 2032-03-24 | Direct | 0 |
Reported balance
After 2023-03-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-03-01 · Disposition to issuer · Disposed 250,000 · Balance 0 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.27 · Expires 2032-03-24 | Direct | 250,000 |
Reported balance
After 2023-03-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2023-03-01 · Grant · Acquired 250,000 · Balance 250,000 F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect the one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023.
F2: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 31, 2023 Filed Jun 3, 2023 00:14 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 5,733 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-23-000043 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,060 F1 · shares: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect the one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023. F1 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect the one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023. F1 · balance_after: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Shares reflect the one-for-ten reverse stock split effected on April 24, 2023 and the one-for-five reverse stock split effected on May 31, 2023. Read SEC document |
| March 27, 2023 Filed Mar 29, 2023 20:11 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingCommon Stock | 11,967 | $0.34 | $4,068.78 |
DisclosureSEC source: 0001615594-23-000022 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 666,327 F1 · shares: Shares were sold to cover withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. F2 · price: The price reported in column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $0.3325 to $0.355, inclusive. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 20:36 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingCommon Stock | 2,276 | $0.31 | $705.56 |
DisclosureSEC source: 0001615594-23-000017 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 678,294 F1 · shares: Shares were sold to cover withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. F2 · price: The price reported in column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $0.3045 to $0.3318, inclusive. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:13 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingCommon Stock | 11,967 | $0.43 | $5,147.01 |
DisclosureSEC source: 0001615594-23-000015 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 680,570 F1 · shares: Shares were sold to cover withholding tax obligations of reporting person in connection with the vesting of Performance Stock Units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:25 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 33,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-23-000009 · primary_doc.xml · nonDerivative · entry 2 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 692,537 F2 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying the award of the performance share units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:25 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 473,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-23-000009 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 659,204 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 01, 2023 Filed Jun 3, 2023 00:14 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 250,000 | Not disclosed Strike: $1.27 | Not disclosed |
DisclosureSEC source: 0001615594-23-000043 · primary_doc.xml · derivative · entry 7 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-03-24 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 3, 2023 00:14 UTC | Cibus, Inc. CLXT · Entity 6658 | Disposition to issuerStock Option (Right-to-Buy) · Derivative | 250,000 | Not disclosed Strike: $1.27 | Not disclosed |
DisclosureSEC source: 0001615594-23-000043 · primary_doc.xml · derivative · entry 6 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2032-03-24 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 3, 2023 00:14 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 24,000 | Not disclosed Strike: $8.05 | Not disclosed |
DisclosureSEC source: 0001615594-23-000043 · primary_doc.xml · derivative · entry 5 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2031-03-12 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 3, 2023 00:14 UTC | Cibus, Inc. CLXT · Entity 6658 | Disposition to issuerStock Option (Right-to-Buy) · Derivative | 24,000 | Not disclosed Strike: $8.05 | Not disclosed |
DisclosureSEC source: 0001615594-23-000043 · primary_doc.xml · derivative · entry 4 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2031-03-12 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 3, 2023 00:14 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 80,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000043 · primary_doc.xml · derivative · entry 3 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-08-04 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| March 01, 2023 Filed Jun 3, 2023 00:14 UTC | Cibus, Inc. CLXT · Entity 6658 | Disposition to issuerStock Option (Right-to-Buy) · Derivative | 80,000 | Not disclosed Strike: $4.55 | Not disclosed |
DisclosureSEC source: 0001615594-23-000043 · primary_doc.xml · derivative · entry 2 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2030-08-04 F2 · kind: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · price: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. F2 · derivative.exercise_date: The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 21:41 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingCommon Stock | 37,573 | $0.15 | $5,542.02 |
DisclosureSEC source: 0001615594-23-000004 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,304 F1 · shares: Shares were withheld to cover tax withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 22:50 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 250,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001615594-22-000019 · primary_doc.xml · derivative · entry 3 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-03-24 F3 · derivative.exercise_date: Option vests as to 25% on each of the first four anniversaries of the date of the grant. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 22:50 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 105,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-22-000019 · primary_doc.xml · nonDerivative · entry 2 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,877 F2 · shares: The Restricted Stock Units reported on this Form 4 vest in full on January 1, 2023. Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 22:50 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-22-000019 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,227 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 22:26 UTC | Cibus, Inc. CLXT · Entity 6658 | Tax withholdingCommon Stock | 2,173 | $1.08 | $2,346.84 |
DisclosureSEC source: 0001615594-22-000015 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,227 F1 · shares: Shares were sold to cover tax withholding obligations of reporting person in connection with the vesting of Restricted Stock Units. Read SEC document |
| March 12, 2021 Filed Mar 18, 2021 20:31 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantRestricted Stock Units · Derivative | 16,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000029 · primary_doc.xml · derivative · entry 3 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 16,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Calyxt, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on March 12, 2022. F3 · derivative.expiration_date: The restricted stock units vest in full on March 12, 2022. Read SEC document |
| March 12, 2021 Filed Mar 18, 2021 20:31 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 24,000 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001615594-21-000029 · primary_doc.xml · derivative · entry 2 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2031-03-12 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 12, 2021 Filed Apr 2, 2021 21:09 UTC Amendment | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 24,000 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001615594-21-000046 · primary_doc.xml · derivative · entry 2 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2031-03-12 F2 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 12, 2021 Filed Apr 2, 2021 21:09 UTC Amendment | Cibus, Inc. CLXT · Entity 6658 | GrantCommon Stock | 16,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000046 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,400 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 22:10 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 150 | $3.79 | $569.00 |
DisclosureSEC source: 0001615594-20-000074 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,900 F1 · shares: The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $3.79 to $3.80, inclusive. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 23:44 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 150 | $3.26 | $489.33 |
DisclosureSEC source: 0001615594-20-000071 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750 F1 · shares: The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $3.23 to $3.28, inclusive. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:57 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 150 | $5.47 | $820.10 |
DisclosureSEC source: 0001615594-20-000068 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 F1 · shares: The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $5.46 to $5.51, inclusive. Read SEC document |
| September 01, 2020 Filed Sep 1, 2020 21:10 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 150 | $5.41 | $811.01 |
DisclosureSEC source: 0001615594-20-000063 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,450 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $5.40 to $5.410, inclusive. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 22:54 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 80,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001615594-20-000056 · primary_doc.xml · derivative · entry 2 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-08-04 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| August 03, 2020 Filed Aug 3, 2020 21:07 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 150 | $4.36 | $653.90 |
DisclosureSEC source: 0001615594-20-000046 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $4.37 to $4.41, inclusive. Read SEC document |
| July 01, 2020 Filed Jul 1, 2020 20:40 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 156 | $5.04 | $786.24 |
DisclosureSEC source: 0001615594-20-000041 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,150 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:26 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 144 | $4.43 | $637.62 |
DisclosureSEC source: 0001615594-20-000033 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,994 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $4.37 to $4.70, inclusive. Read SEC document |
| May 01, 2020 Filed May 4, 2020 18:34 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 175 | $4.32 | $755.30 |
DisclosureSEC source: 0001615594-20-000027 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,850 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $4.31 to $4.35, inclusive. Read SEC document |
| April 01, 2020 Filed Apr 1, 2020 20:30 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 175 | $3.19 | $559.09 |
DisclosureSEC source: 0001615594-20-000019 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,675 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $3.16-$3.25, inclusive. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:12 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 200 | $6.43 | $1,286.00 |
DisclosureSEC source: 0001615594-20-000017 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 F1 · kind: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. Read SEC document |
| February 03, 2020 Filed Feb 4, 2020 13:40 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 200 | $5.61 | $1,122.00 |
DisclosureSEC source: 0001615594-20-000007 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · kind: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 20:12 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 275 | $7.89 | $2,169.75 |
DisclosureSEC source: 0001615594-20-000005 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100 F1 · kind: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. Read SEC document |
| January 14, 2020 Filed Jan 14, 2020 19:05 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 275 | $7.24 | $1,990.12 |
DisclosureSEC source: 0001615594-20-000004 · primary_doc.xml · nonDerivative · entry 2 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 F1 · kind: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $7.12 to $7.37, inclusive. Read SEC document |
| January 13, 2020 Filed Jan 14, 2020 19:05 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 275 | $7.19 | $1,977.25 |
DisclosureSEC source: 0001615594-20-000004 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550 F1 · kind: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. Read SEC document |
| January 10, 2020 Filed Jan 13, 2020 15:38 UTC | Cibus, Inc. CLXT · Entity 6658 | PurchaseCommon Stock | 275 | $7.64 | $2,101.00 |
DisclosureSEC source: 0001615594-20-000003 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275 F1 · kind: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. Read SEC document |
| May 20, 2019 Filed May 23, 2019 20:39 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $14.72 | $0.00 |
DisclosureSEC source: 0001127602-19-019646 · form4.xml · derivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-05-20 F1 · derivative.exercise_date: The Stock Options were granted on May 20, 2019 and vest 15% on the first anniversary of the grant date and 10% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 45 months (commencing on September 30, 2021). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.